Dennis Depenbusch

Dennis Depenbusch is an experienced professional with a robust background in corporate venture capital and board governance. Currently serving as a Member of the Board of Directors at Predict Health, Inc. and involved with BlueCross and BlueShield of Kansas since October 2015, Dennis leads a $50 million venture capital fund focused on enhancing the healthcare market in Kansas and beyond. Additionally, Dennis holds board observer roles at several health-related companies, including Manatee and Sonara Health, and has previously served on the boards of Aclaimant and Tonic Health. Notable past achievements include successful exits with Flock and BeMe Health. Dennis holds an MBA in Business Finance from the University of Kansas and a Bachelor of Science in Business Administration from the same institution.